Why Young Colorectal Cancer Rates are Surging in Korea: The Paradox of “High-Quality” Protein
The common refrain "you have to eat meat to have strength" reflects a cultural sentiment in Korea that is anything but ordinary.
Search results for "tumor"
Predicting a Rare Disease from the Back of Your Hand: AI Breakthrough in Acromegaly Detection
While palm lines are traditionally used in folklore to predict the future, a new scientific study suggests that the back of your hand may offer even...
"I Lost 10kg to Save My Mother": The Son Who Overcame Fatty Liver for a Life-Saving Transplant
"Since this is a new life I gained thanks to my son, I will take better care of my health and live the rest of my life...
Kidney Cancer Risk in Women Over 50: The Hidden Link to Obesity and Hypertension
The kidneys, a pair of bean-shaped organs located on either side of the spine, serve as the body’s essential filtration...
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
‘A Child is Not a Small Adult’ Practicing Children's Hospital Model
“In the early morning, my five-year-old was rolling around in pain. I searched just in case, and to my surprise, the...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal
ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...